Technology | May 04, 2009

UltraSPECT Introduces the Xpress3.Cardiac Image Reconstruction in U.S.

May 4, 2009 –UltraSPECT said April 30 it intends to offer the Xpress3.Cardiac SPECT WBR-based SPECT image reconstruction package for sale in the U.S., which the company said enables short acquisition times with good resolution.

The Xpress3.Cardiac reportedly enables short scan times without compromising image quality and diagnostic confidence. The company said the scan times are three minutes for stress and less than five minutes for rest. The Xpress3.Cardiac was FDA cleared in May of 2008 and was showcased at the ASNC 2008 Annual Meeting last September in Boston. The product has since been in routine clinical use at a limited number of sites in the U.S. and Europe, including St. Luke's Roosevelt Hospital in New York City, Mayo Clinic, Duke University Medical Center, Baptist Hospital of Miami, and Atlanta Heart Specialists.

The Xpress3.Cardiac is fully automatic, with a single processing protocol for all patients. The hardware platform is based on a quad-core CPU, which can be connected to the gamma camera and workstation network in a matter of hours. The company said this enables quarter-time image acquisition with reconstructions that are the same or better than using standard imaging times. UltraSPECT said there is no extra work required of the technologist, as the image reconstruction process is completely transparent to the department's clinical workflow.

The Xpress3.Cardiac, along with UltraSPECT’s Xpress.Cardiac and Xpress/Xact.Bone products, are exclusively distributed in the U.S. by Cardinal Health.

For more information: www.ultraspect.com

Related Content

advanced visualization
News | Molecular Imaging | June 09, 2017
The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens Healthineers...
News | SPECT-CT | June 08, 2017
Siemens Healthineers debuts Symbia Intevo Bold at the 2017 annual meeting of the Society of Nuclear Medicine &...
Sponsored Content | Videos | Nuclear Imaging | April 28, 2017
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American S
SPECT/CT Imaging Test Shown Accurate in Ruling Out Kidney Cancers
News | SPECT Imaging | April 24, 2017
The latest in a series of studies led by researchers at Johns Hopkins Medicine shows that addition of a widely...
brain SPECT imaging, dementia, depression, Daniel G. Amen

Representative brain SPECT scans in a patient with Alzheimer's dementia showing substantially reduced brain blood flow in the temporal and parietal lobes compared to a person with depression with mild decreased frontal lobe blood flow. Image courtesy of Amen Clinics.

News | SPECT Imaging | February 22, 2017
February 22, 2017 — Does a patient have depression or a cognitive disorder (CD) such as Alzheimer's disease or both?
News | Nuclear Imaging | December 12, 2016
Molecular Targeting Technologies, Inc. (MTTI) announces that response of colorectal cancer to treatment can be detected...
xSPECT Quant technology, SPECT/CT, Symbia Intevo, Siemens Healthineers, RSNA 2016
News | SPECT Imaging | December 06, 2016
December 6, 2016 — At the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (
News | Radiopharmaceuticals and Tracers | September 06, 2016
Navidea Biopharmaceuticals Inc. announced that it has executed a Letter of Intent (LOI) with Cardinal Health for the...
UltraSPECT, Xpress3.Cardiac, nuclear imaging, RWJPE, New Jersey, Robert Wood Johnson Physician Enterprise
News | SPECT Imaging | July 25, 2016
UltraSPECT Inc. announced recently that Robert Wood Johnson Physician Enterprise (RWJPE), a multi-specialty, community-...
neuroendocrine tumors, NET, radiotherapy dose, PET, SPECT, SNMMI 2016

Comparison of Ga-68-DOTATOC PET/CT with Y-90 DOTATOC PET/CT. Although the positron associated with Y-90 is rarely emitted, there is still sufficient signal to acquire a quantitative PET/CT image of Y-90 DOTATOC after a therapeutic administration. The white arrows indicate kidneys and the yellow arrows tumor. Credit: University of Iowa

News | Nuclear Imaging | June 23, 2016
Aggressive neuroendocrine cancer is something of a dark horse — a rare, elusive and persevering force linked to...
Overlay Init